A meeting to bring together public and private sector agencies, organizations, and companies working to overcome the drawbacks of administering vaccines and other medicaments with conventional needle and syringe.

Tentative Agenda Sessions and Presentations (updated 10 March 1999) :

• NEEDLE-FREE INJECTION: NEEDS AND CHALLENGES

• Needle-free Technology: Past, Present, and Future
• Injection Safety: Global Perspective and Plans for Action
• Bridging Public Health Needs with Commercial and Technical Realities
• US Military Experience, Policy, and Plans for Needle-free Vaccination
• Panel Discussion

• DEVELOPED COUNTRY MARKETS: WHAT ROLE FOR NEEDLE-FREE?

• Potential Market and Demand for Needle-free Immunization in the United States
• New Occupational Needle-safety Regulation: What Role Might Needle-free Injection Play?
• Case Study in Marketing a Needle-free Injector in the U.S.: Biojector 2000®
• Regulatory Compliance and Validation Issues: Recent Experience Introducing to Market a New Needle-free Injector
• Panel Discussion

• DEVELOPING COUNTRIES: DO MARKETS EXIST? HOW TO FIND THEM?

• Immunization Programs in Developing Countries: Scenarios and Economics for Needle-free Utilization
• Mass Campaigns: Measles Eradication, Meningitis Outbreaks, Swine Flu Pandemic
• Developing Country Markets for New Injection Technologies: Perspective of a Global Supplier
• Economic Analysis of the Hidden Costs of Needles/Syringes in Africa
• Panel Discussion

• SPECIAL REPORT

• Highlights from the 4th Annual Conference on Needle-free and Auto Injectors, Management Forum, Ltd., London, UK, 22-23 February 1999

• RECONSIDERING REUSABLE NOZZLES: EVALUATIONS OF SAFETY

• Bovine Model Pioneered in London for Safety Evaluation of Multiple-use Nozzle Jet Injectors
• Update on Evaluation in Brazil of Multiple-use Nozzle Jet Injector Safety in Human Subjects
• Update on Bridging the Bovine Safety Evaluation Method to a Porcine Model
• Weighing Risks vs. Benefits with Injection Technologies
• PATH's Jet Injector Tests as Design and Development Tools
• Panel Discussion

• STANDARDIZING CARTRIDGE-DEVICE INTERFACES AND PREFILLING VACCINE: WISHFUL DREAMING OR ATTAINABLE GOALS?

• Cartridge Standardization: Design, Interface, and Procedural Issues
• Lessons Learned in Bringing to Market a New, Prefilled Vaccination Device: the UniJect^TM
• Experience from Standardizing Insulin Cartridges and Auto Pen Injectors
• Review of the Pasteur Mérieux Connaught Experience with the Imule^TM Prefilled Liquid Vaccine Capsule: Basis for Development, Strategy, and Results
• Perspective of a U.S. Vaccine Manufacturer on Prefilling Vaccine and Cartridge Standardization
• Panel Discussion

• EVOLVING APPROACHES FOR NEEDLE-FREE DEVICE REGULATION

• Current and Potential FDA Requirements for Needle-free Device Licensure
• FDA Biologics Perspective on Needle-free Vaccination Device Regulation
• European Directive for Medical Devices and the "Vienna Agreement" for Cooperation between ISO and CEN: Implications for Needle-free Injectors
• New California Sharps Legislation: Impact on Institutions and Users
• Panel Discussion

• NEXT STEPS: ROLES AND RESPONSIBILITIES OF PUBLIC AND PRIVATE SECTORS

• Panel Discussion

• DEVELOPER/MANUFACTURER PRESENTATIONS AND NEEDLE-FREE DEVICE DEMONSTRATIONS

• American Jet Injector, Inc. (Am-O-Jet^TM)
• Bioject, Inc. (Biojector 2000®, Vitajet®)
• D'Antonio Consultants International, Inc. (DCI)
• Equidyne Systems, Inc. (INJEX^TM)
• National Medical Products, Inc. (J-TIP^TM)
• IOMAI, Inc.
• PowderJect, Inc. (PowderJect®)
• Other manufacturers and developers - to be announced

• ANFIM BUSINESS MEETING

To obtain a PDF version of this Registration form, click here.            (Please type or print)
 
 

_____________________________________________________________________________________________
Given Name                                 Middle Initial                                         Family Name                           Degree(s)

_____________________________________________________________________________________________
Position or Title

_____________________________________________________________________________________________
Company/Organization

_____________________________________________________________________________________________
Address                                           City                                     State                         Zip                     Country

_____________________________________________________________________________________________
Phone                                                                          Fax                                               Internet e-Mail address

Payment

Individual Registration Fee

Only registered badge-carrying participants will be admitted to conference sessions.

ANFIM Annual Dues (optional, extra)

Companies or organizations planning to participate in the ANFIM (Association of Needle-free Injection Manufacturers) business meeting on late Wednesday afternoon must submit one annual dues payment which will cover all participating employees.

ANFIM
880 Orchard Lane
Lansdale, PA 19446-4520 USA
Tel: [+1](215)362-4815

Contact the hotel directly to make a reservation, citing the "Needle-free injection conference". A limited number of guest rooms are being held until February 28, 1999 at the special rate of $129 per night, plus taxes. Meeting sessions run from 8:30 am Wednesday through 4:30 pm on Thursday.

Hyatt Regency Bethesda Hotel
One Bethesda Metro Center
Wisconsin Ave. at Old Georgetown Rd.
Bethesda, Maryland 20814 USA
Tel: [+1] (301) 657-1234
Toll-free in U.S.: [+1] (800) 233-1234
Fax: [+1] (301) 657-6451

Further Information

For additional program or logistics information, please contact:

Ms. Elizabeth Perry
National Immunization Program
Centers for Disease Control and Prevention
Mailstop E-52, 1600 Clifton Road
Atlanta, Georgia 30333 USA
Tel: (404) 639-8638
Fax: (404) 639-8614
E-mail: epp1@cdc.gov

• Needle-free Injection Technology Page
• NIP Home Page
• CDC Home Page